Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38207
CAS Number:
110078-46-1
Plérixafor
Purity:
≥ 98% (CG)
Synonym(s):
1,4-Bis[(1,4,8,11-tétraazacyclotétradécan-1-yl)méthyl]benzène, AMD 3100
Documents
$126.39 /50 mg
Taille
Request Bulk Quote
Informations sur le produit

Conserver sous gaz inerte

Numéro CAS 
110078-46-1
Formule moléculaire
C 28 H 54 N 8
Poids moléculaire 
502.8
Point de fusion 
131 - 135 °C
Informations générales
Numéro CAS 
110078-46-1
Formule moléculaire
C 28 H 54 N 8
Poids moléculaire 
502.8
Point de fusion 
131 - 135 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Plerixafor is widely utilized in research focused on:

  • Stem Cell Mobilization: It is primarily used to enhance the mobilization of hematopoietic stem cells from the bone marrow into the bloodstream, which is crucial for patients undergoing stem cell transplantation.
  • Cancer Treatment: Plerixafor is applied in oncology to improve the collection of stem cells for patients with certain types of blood cancers, such as multiple myeloma and non-Hodgkin lymphoma, facilitating more effective treatments.
  • Clinical Trials: Researchers employ this compound in clinical studies to evaluate its efficacy in combination with other therapies, helping to advance cancer treatment protocols.
  • HIV Research: It is also explored in HIV research for its ability to block the CXCR4 receptor, which may lead to new therapeutic strategies for managing HIV infection.
  • Pharmaceutical Development: The compound serves as a model in drug development for understanding receptor interactions and designing new drugs targeting similar pathways, enhancing the pharmaceutical industry's innovation.

Citations